Successful pregnancy after cladribine therapy for hairy cell leukemia

Leukemia and Lymphoma

Volumn 45, Issue 1, 2004, Pages 187-188

  Orlowski, Robert Z ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Cladribine; Hairy cell leukaemia; Pregnancy

Indexed keywords

ANTIBIOTIC AGENT; CD103 ANTIGEN; CD20 ANTIGEN; CLADRIBINE; GLYCOPROTEIN P 15095; ORAL CONTRACEPTIVE AGENT;

ADULT; AGE; ARTICLE; BONE MARROW BIOPSY; CANCER DIAGNOSIS; CASE REPORT; COUGHING; DNA STRAND BREAKAGE; DRUG INDICATION; DRUG INFUSION; FEMALE; FEMALE FERTILITY; FLOW CYTOMETRY; FOLLOW UP; HAIRY CELL LEUKEMIA; HUMAN; LEUKEMIA REMISSION; MENSTRUATION DISORDER; NOSE CONGESTION; ORAL CONTRACEPTION; OVARY FUNCTION; PREGNANCY; PRENATAL CARE; PRIORITY JOURNAL; SORE THROAT; TREATMENT OUTCOME; VAGINAL DELIVERY;

ADULT; CLADRIBINE; FEMALE; HUMANS; LEUKEMIA, HAIRY CELL; PREGNANCY; TIME FACTORS;

EID: 0842301519     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.1080/1042819031000149458     Document Type: Article

References (22)

1. Pettitt, A.R., Zuzel, M. and Cawley, J.C. (1999) "Hairy-cell leukaemia: biology and management", British Journal of Haematology, 106, 2-8.
2. Andrey, J. and Saven, A. (2001) "Therapeutic advances in the treatment of hairy cell leukemia", Leukemia Research, 25, 361-368.
3. Baer, M.R., Ozer, H. and Foon, K.A. (1992) "Interferon-alpha therapy during pregnancy in chronic myelogenous leukaemia and hairy cell leukaemia", British Journal of Haematology, 81, 167-169.
4. Williams, J.K. (1987) "Hairy cell leukemia in pregnancy: a case report", American Journal of Obstetrics and Gynecology, 156, 210-211.
5. Alothman, A. and Sparling, T.G. (1994) "Managing hairy cell leukemia in pregnancy", Annals of Internal Medicine, 120, 1048-1049.
6. Stiles, G.M., Stanco, L.M., Saven, A. and Hoffmann, K.D. (1998) "Splenectomy for hairy cell leukemia in pregnancy", Journal of Perinatology, 18, 200-201.
7. Blumenfeld, Z., Avivi, I., Ritter, M. and Rowe, J.M. (1999) "Preservation of fertility and ovarian function and minimizing chemotherapy-induced gonadotoxicity in young women", Journal of the Society for Gynecologic Investigation, 6, 229-239.
8. Seto, S., Carrera, C.J., Kubota, M., Wasson, D.B. and Carson, D.A. (1985) "Mechanism of deoxyadenosine and 2-chlorodeoxyadenosine toxicity to nondividing human lymphocytes", Journal of Clinical Investigation, 75, 377-383.
9. Hirota, Y., Yoshioka, A., Tanaka S., Watanabe, K., Otani, T., Minowada, J., et al. (1989) "Imbalance of deoxyribonucleoside triphosphates, DNA double-strand breaks, and cell death caused by 2-chlorodeoxyadenosine in mouse FM3A cells", Cancer Research, 49, 915-919.
10. Schimmer, A.D., Quatermain, M., Imrie, K., Ali, V., McCrae, J., Stewart, A.K., et al. (1998) "Ovarian function after autologous bone marrow transplantation", Journal of Clinical Oncology, 16, 2359-2363.
11. Teinturier, C., Hartmann, O., Valteau-Couanet, D., Benhamou, E. and Bougneres, P.F. (1998) "Ovarian function after autologous bone marrow transplantation in childhood: high-dose busulfan is a major cause of ovarian failure", Bone Marrow Transplantation, 22, 989-994.
12. Meirow, D. (2000) "Reproduction post-chemotherapy in young cancer patients", Molecular and Cellular Endocrinology, 169, 123-131.
13. Chapman, R.M., Sutcliffe, S.B. and Malpas, J.S. (1979) "Cytotoxic-induced ovarian failure in women with Hodgkin's disease. I. Hormone function", Journal of the American Medical Association, 242, 1877-1881.
14. Whitehead, E., Shalet, S.M., Blackledge, G., Todd, I., Crowther, D. and Beardwell, C.G. (1983) "The effect of combination chemotherapy on ovarian function in women treated for Hodgkin's disease", Cancer, 52, 988-993.
15. Bokemeyer, C., Schmoll, H.J., van Rhee, J., Kuczyk, M., Schuppert, F. and Poliwoda, H. (1994) "Long-term gonadal toxicity after therapy for Hodgkin's and non-Hodgkin's lymphoma", Annals of Hematology, 68, 105-110.
16. Clark, S.T., Radford, J.A., Crowther, D., Swindell, R. and Shalet, S.M. (1995) "Gonadal function following chemotherapy for Hodgkin's disease: a comparative study of MVPP and a seven-drug hybrid regimen", Journal of Clinical Oncology, 13, 134-139.
17. Mackie, E.J., Radford, M. and Shalet, S.M. (1996) "Gonadal function following chemotherapy for childhood Hodgkin's disease", Medical and Pediatric Oncology, 27, 74-78.
18. Partridge, A.H., Burstein, H.J. and Winer, E.P. (2001) "Side effects of chemotherapy and combined chemohormonal therapy in women with early-stage breast cancer", Journal of the National Cancer Institute Monographs, 30, 135-142.
19. Lower, E.E., Blau, R., Gazder, P. and Tummala, R. (1999) "The risk of premature menopause induced by chemotherapy for early breast cancer", Journal of Womens Health and Gender Based Medicine, 8, 949-954.
20. Laml, T., Schulz-Lobmeyr, I., Obruca, A., Huber, J.C. and Hartmann, B.W. (2000) "Premature ovarian failure: etiology and prospects", Gynecological Endocrinology, 14, 292-302.
21. Revel, A. and Laufer, N. (2002) "Protecting female fertility from cancer therapy", Molecular and Cellular Endocrinology, 187, 83-91.
22. Chapman, R.M. and Sutcliffe, S.B. (1981) "Protection of ovarian function by oral contraceptives in women receiving chemotherapy for Hodgkin's disease", Blood, 58, 849-851.